Transmedics Group Inc (TMDX)

EBITDA

$130.22M

TTM · Period ending: · USD

TMDX logo

TMDX EBITDA

Latest reported$130.22M
TMDX TTM EBITDA (-$19.91M → $130.22M)
High-resolution chart · PNG

TMDX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Transmedics Group Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
130,217,000
139,734,000
148,489,000
132,274,000
111,942,000
85,928,000
70,047,000
64,880,000
30,395,000
12,937,000
-7,703,000
-23,185,000
-7,468,000
-20,119,000
-28,961,000
-35,759,000
-41,549,000
-41,061,000
-38,488,000
-32,181,000
-24,371,000
-22,241,000
-23,154,000
-26,002,000
-29,147,000
-29,814,000
-27,932,000
-26,509,000
-23,463,000
-21,470,000
-20,538,000
-18,550,000
-19,296,000
-19,075,000
-19,912,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.